Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by abrdn plc

abrdn plc lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 86.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,974 shares of the company's stock after selling 57,529 shares during the period. abrdn plc's holdings in Bath & Body Works were worth $284,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of BBWI. First Community Trust NA purchased a new stake in shares of Bath & Body Works in the second quarter valued at approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock worth $38,000 after buying an additional 900 shares in the last quarter. GAMMA Investing LLC raised its stake in Bath & Body Works by 65.4% in the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company's stock worth $72,000 after buying an additional 730 shares in the last quarter. EntryPoint Capital LLC raised its stake in Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company's stock worth $74,000 after buying an additional 1,017 shares in the last quarter. Finally, Blue Trust Inc. raised its stake in Bath & Body Works by 23.4% in the second quarter. Blue Trust Inc. now owns 2,767 shares of the company's stock worth $108,000 after buying an additional 524 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of NYSE BBWI traded up $0.13 during mid-day trading on Wednesday, hitting $31.75. The stock had a trading volume of 8,169,418 shares, compared to its average volume of 3,752,129. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The firm has a market cap of $6.96 billion, a PE ratio of 7.72, a PEG ratio of 0.92 and a beta of 1.79. The company has a 50 day moving average of $30.02 and a two-hundred day moving average of $37.16.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Equities research analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.52%. The ex-dividend date was Friday, August 23rd. Bath & Body Works's payout ratio is currently 19.37%.

Insider Transactions at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.27% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on BBWI shares. Wells Fargo & Company reduced their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an "equal weight" rating for the company in a research note on Wednesday. Telsey Advisory Group reaffirmed an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Thursday, September 26th. Citigroup reduced their price target on Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 20th. UBS Group reduced their price target on Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating on the stock in a research report on Thursday, August 29th. Finally, Robert W. Baird reduced their price target on Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a research report on Thursday, August 29th. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $42.63.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.